Relay Therapeutics' GAAP loss for 2021 was $363.872 million, up 6.9 times from $52.412 million in the previous year. Revenue declined 27.7 times to $3.029 million from $82.654 million a year earlier.
Relay Therapeutics' GAAP loss for 2021 was $363.872 million, up 6.9 times from $52.412 million in the previous year. Revenue declined 27.7 times to $3.029 million from $82.654 million a year earlier. 
ir.relaytx.com
English (US) 